Activation of Loop 1, which enhances the M1 and TD productions, can promote the M1/M2-type COPD while Loops 2 and 4 contribute to the (Th17+CD8+T)/Treg-type disease where IL-6 and IL-17 are key molecules for the disease progression. Here, IL17A is linked to chronic obstructive pulmonary disease.